| RADNOR, Pa., Feb. 28, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat serious acute-care conditions, announced today that Nicholas Landekic, the Company's President & CEO will present at the Cowen and Company 32 nd Annual Health Care Conference on Tuesday, March 6 th at 8:40 a.m. Eastern Time. The conference is being held at the Boston Marriott Copley Place. A live webcast of Mr. Landekic's presentation...continued PYMX heparin antibiotics lovenox |
Tuesday, February 28, 2012
PolyMedix to Present at the Cowen 32nd Annual Health Care Conference
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment